Journal
MOLECULAR NUTRITION & FOOD RESEARCH
Volume 63, Issue 21, Pages -Publisher
WILEY
DOI: 10.1002/mnfr.201801230
Keywords
Alzheimer's disease; caspase-11; EGCG; NLRP3 inflammasome; TLR4; NF-kappa B
Categories
Funding
- National Natural Science Foundation of China [81501098, 81603112, 81703519, 81803751]
- Double Hundred Program for Shenyang Scientific and Technological Innovation Projects [100040]
- Drug Innovation Major Project of National High Technology Research and Development Program of China [2018ZX09711001-008-006]
- Program for Liaoning Innovation Research Team in University [LT2014016]
- Scientific Research Fund of Liaoning Provincial Education Department [LK201608]
- Key Laboratory Foundation from Shenyang ST Projects [F16-094-1-00]
- Liaoning Province Scientific Research Foundation [2014226033]
Ask authors/readers for more resources
Scope In this study, it has been investigated whether the neuroprotective efficacy of epigallocatechin-3-gallate (EGCG) is mediated by inhibition of canonical and noncanonical inflammasome activation via toll-like receptor 4 (TLR4)/NF-kappa B pathway both in LPS+A beta-induced microglia in vitro and in APP/PS1 mice in vivo. Methods and results In BV2 cells, EGCG inhibits the expressions of Iba-1, cleaved IL-1 beta, and cleaved IL-18 induced by LPS+A beta. Then, the supernatants are used to treat SH-SY5Y cells, and EGCG treatment significantly recovers the neurotoxicity from LPS+A beta-induced microglial conditioned media. Subsequently, it has been found that EGCG reduces the microglial expressions of caspase-1 p20, NLRP3, and caspase-11 p26. Furthermore, the expression levels of Toll-like receptor 4 (TLR4), p-IKK/IKK, and p-NF-kappa B/NF-kappa B were decreased after EGCG treatment. As expected, when a caspase-1 specific inhibitor Z-YVAD-FMK, and an IKK and caspase-11 inhibitor wedelolactone are used for blocking, Z-YVAD-FMK and wedelolactone exacerbate the inhibitory efficacy than using EGCG alone. Finally, consistent with the results obtained in BV2 cells, EGCG treatment reduces microglial inflammation and neurotoxicity by suppressing the activation of canonical NLRP3 and noncanonical caspase-11-dependent inflammasome via TLR4/NF-kappa B pathway in LPS+A beta-induced rat primary microglia and hippocampus of APP/PS1 mice. Conclusion EGCG attenuates microglial inflammation and neurotoxicity by inhibition of canonical NLRP3 and noncanonical caspase-11-dependent inflammasome activation via TLR4/NF-kappa B pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available